Lack of paradoxical bronchoconstriction after administration of tiotropium via Respimat® Soft Mist™ Inhaler in COPD.
第一作者:
Rick,Hodder
第一单位:
Division of Pulmonary Care, University of Ottawa, Ottawa, ON, Canada. rhodder@toh.on.ca
作者:
医学主题词
投药, 吸入(Administration, Inhalation);老年人(Aged);支气管痉挛(Bronchial Spasm);支气管收缩(Bronchoconstriction);支气管扩张药(Bronchodilator Agents);胆碱能拮抗剂(Cholinergic Antagonists);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);女(雌)性(Female);用力呼气量(Forced Expiratory Volume);人类(Humans);Logistic模型(Logistic Models);肺(Lung);男(雄)性(Male);中年人(Middle Aged);多中心研究(主题)(Multicenter Studies as Topic);雾化器和汽化器(Nebulizers and Vaporizers);肺疾病, 慢性阻塞性(Pulmonary Disease, Chronic Obstructive);随机对照试验(主题)(Randomized Controlled Trials as Topic);回顾性研究(Retrospective Studies);危险性评估(Risk Assessment);东莨菪碱衍生物(Scopolamine Derivatives);治疗结果(Treatment Outcome);肺活量(Vital Capacity)
DOI
10.2147/COPD.S16094
PMID
21814460
发布时间
2021-10-20
- 浏览78
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



